Balancing efficiency, cost-effectiveness and patient choice in opioid selection

Area of Science:

• Palliative Care
• Pain Management
• Health Policy

Background:

• UK government initiatives emphasize patient choice in healthcare.
• Palliative care aims to maximize quality of life and respect patient autonomy.
• Analgesic selection involves evaluating efficacy, potency, delivery, adverse effects, and cost.

Purpose of the Study:

• To explore the rationale for choosing strong opioids in palliative care.
• To examine the role of patient choice in opioid selection.
• To assess the balance between individual needs and cost-effectiveness in opioid prescribing.

Main Methods:

• Literature review on strong opioid selection in palliative care.
• Analysis of factors influencing analgesic choice.
• Discussion of patient autonomy versus economic considerations.

Main Results:

• Morphine and diamorphine are often considered first-line strong opioids.
• Patient choice may necessitate a more flexible approach to opioid selection.
• Cost-effectiveness can restrict the scope of opioid choices available.

Conclusions:

• Opioid selection in palliative care should prioritize quality of life and patient preferences.
• A flexible approach to strong opioid choice is warranted, considering individual circumstances.
• Ensuring the patient's voice is heard is paramount in palliative pain management decisions.